Bacitracin / Neomycin / Polymyxin B Ophthalmic Side Effects
Medically reviewed by Drugs.com. Last updated on Jun 21, 2024.
Applies to bacitracin/neomycin/polymyxin b ophthalmic: ophthalmic ointment.
Serious side effects
Along with its needed effects, bacitracin/neomycin/polymyxin b ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking bacitracin/neomycin/polymyxin b ophthalmic:
More common side effects
After application, eye ointments usually cause your vision to blur for a few minutes.
For healthcare professionals
Applies to bacitracin / neomycin / polymyxin b ophthalmic: ophthalmic ointment.
Hypersensitivity adverse events
- Frequency not reported: Allergic sensitization reactions (including itching, swelling, conjunctival erythema), more serious hypersensitivity reactions (including anaphylaxis)[Ref]
Local
- Frequency not reported: Local irritation upon administration[Ref]
References
1. (2022) "Product Information. Neosporin Ophthalmic (gramicidin/neomycin/polymyxin B ophthalmic)." Monarch Pharmaceuticals Inc
Frequently asked questions
More about bacitracin / neomycin / polymyxin b ophthalmic
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Dosage information
- During pregnancy
- Drug class: ophthalmic anti-infectives
- En español
Patient resources
- Bacitracin, neomycin, and polymyxin B ophthalmic drug information
- Neomycin, polymyxin b, and bacitracin (Ophthalmic) (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Bacitracin/neomycin/polymyxin b ophthalmic side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.